PRESS RELEASE published on 09/13/2023 at 14:00, 2 years 11 months ago Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis
PRESS RELEASE published on 06/22/2023 at 10:30, 3 years 2 months ago Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis
PRESS RELEASE published on 03/01/2023 at 13:00, 3 years 5 months ago Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes
Published on 08/24/2026 at 07:45, 2 hours 11 minutes ago Sinopec Achieves Solid Operating Results in the First Half of 2026
Published on 08/22/2026 at 05:50, 2 days 4 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 2 days 5 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 2 days 9 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 2 days 10 hours ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/24/2026 at 09:35, 21 minutes ago 2026 Taiwan Jewellery & Gem Fair to Take Place in November
Published on 08/24/2026 at 09:00, 55 minutes ago Original-Research: SYNBIOTIC SE (von NuWays AG): Under review
Published on 08/24/2026 at 08:56, 59 minutes ago IBU-tec fully on track in the first half of 2026 / Focus on capacity build-up for large LFP plant
Published on 08/21/2026 at 18:33, 2 days 15 hours ago 260821 BENETEAU Transaction sur actions propres
Published on 08/18/2026 at 18:00, 5 days 15 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 5 days 16 hours ago Mise à disposition du rapport financier annuel 2025-26
